{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:01:16Z","timestamp":1773874876673,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"crossref","award":["CP14\/00198"],"award-info":[{"award-number":["CP14\/00198"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12916-018-1026-6","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T05:48:09Z","timestamp":1519796889000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Class-modeling analysis reveals T-cell homeostasis disturbances involved in loss of immune control in elite controllers"],"prefix":"10.1186","volume":"16","author":[{"name":"On behalf of ECRIS integrated in the Spanish AIDS Research Network","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Benito","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda C.","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agathe","family":"Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Sarabia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"Ligos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Montoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcial","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezequiel","family":"Ruiz-Mateos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosario","family":"Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Cabello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"del Romero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda A.","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Alcam\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"G\u00f3rgolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norma","family":"Rall\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,28]]},"reference":[{"key":"1026_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/QAI.0b013e3181945f1e","volume":"50","author":"MM Sajadi","year":"2009","unstructured":"Sajadi MM, Constantine NT, Mann DL, Charurat M, Dadzan E, Kadlecik P, et al. Epidemiologic characteristics and natural history of HIV-1 natural viral suppressors. J Acquir Immune Defic Syndr. 2009;50:403\u20138.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"1026_CR2","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/COH.0b013e328345a328","volume":"6","author":"B Autran","year":"2011","unstructured":"Autran B, Descours B, Avettand-Fenoel V, Rouzioux C. Elite controllers as a model of functional cure. Curr Opin HIV and AIDS. 2011;6:181\u20137.","journal-title":"Curr Opin HIV and AIDS."},{"key":"1026_CR3","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.tim.2014.11.003","volume":"23","author":"LR Cockerham","year":"2015","unstructured":"Cockerham LR, Hatano H. Elite control of HIV: is this the right model for a functional cure? Trends Microbiol. 2015;23:71\u20135.","journal-title":"Trends Microbiol."},{"key":"1026_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2013.00162","volume":"4","author":"D Shasha","year":"2013","unstructured":"Shasha D, Walker BD. Lessons to be learned from natural control of HIV\u2014future directions, therapeutic, and preventive implications. Front Immunol. 2013;4:1\u20138.","journal-title":"Front Immunol."},{"key":"1026_CR5","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.immuni.2007.08.010","volume":"27","author":"SG Deeks","year":"2007","unstructured":"Deeks SG, Walker BD. Human immunodeficiency virus controllers: mechanisms of durable virus control in the absence of antiretroviral therapy. Immunity. 2007;27:406\u201316.","journal-title":"Immunity."},{"key":"1026_CR6","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1086\/526786","volume":"197","author":"F Pereyra","year":"2008","unstructured":"Pereyra F, Addo M, Kaufmann DE, Liu Y, Miura T, Rathod A, et al. Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy. J Infect Dis. 2008;197:563\u201371.","journal-title":"J Infect Dis."},{"key":"1026_CR7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/nri3478","volume":"13","author":"BD Walker","year":"2013","unstructured":"Walker BD, Yu XG. Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol. 2013;13:487\u201398.","journal-title":"Nat Rev Immunol."},{"key":"1026_CR8","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1097\/01.aids.0000194134.28135.cd","volume":"19","author":"Y Madec","year":"2005","unstructured":"Madec Y, Boufassa F, Porter K, Meyer L. CASCADE collaboration. Spontaneous control of viral load and CD4 cell count progression among HIV-1 seroconverters. AIDS. 2005;19:2001\u20137.","journal-title":"AIDS."},{"key":"1026_CR9","doi-asserted-by":"publisher","first-page":"e18726","DOI":"10.1371\/journal.pone.0018726","volume":"6","author":"F Boufassa","year":"2011","unstructured":"Boufassa F, Saez-Ciri\u00f3n A, Lechenadec J, Zucman D, Avettand-Fenoel V, Venet A, et al. CD4 dynamics over a 15 year-period among HIV controllers enrolled in the ANRS French observatory. PLoS One. 2011;6:e18726.","journal-title":"PLoS One."},{"key":"1026_CR10","doi-asserted-by":"publisher","first-page":"e0131922","DOI":"10.1371\/journal.pone.0131922","volume":"10","author":"N Noel","year":"2015","unstructured":"Noel N, Lerolle N, Lecuroux C, Goujard C, Venet A, Saez-Ciri\u00f3n A, et al. Immunologic and virologic progression in HIV controllers: the role of viral blips and immune activation in the ANRS CO21 CODEX study. PLoS One. 2015;10:e0131922.","journal-title":"PLoS One."},{"key":"1026_CR11","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1097\/QAD.0000000000001050","volume":"30","author":"A Leon","year":"2016","unstructured":"Leon A, Perez I, Ruiz-Mateos E, Benito JM, Leal M, Lopez-Galindez C, et al. Rate and predictors of progression in elite and viremic HIV-1 controllers. AIDS. 2016;30:1209\u201320.","journal-title":"AIDS."},{"key":"1026_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye AA, Picker LJ. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol Rev. 2013;254:54\u201364.","journal-title":"Immunol Rev."},{"key":"1026_CR13","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/imr.12079","volume":"254","author":"M Paiardini","year":"2013","unstructured":"Paiardini M, Muller-Trutwin M. HIV-associated chronic immune activation. Immunol Rev. 2013;254:78\u2013101.","journal-title":"Immunol Rev."},{"key":"1026_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1146\/annurev-pathol-011110-130254","volume":"6","author":"S Moir","year":"2011","unstructured":"Moir S, Chun TW, Fauci AS. Pathogenic mechanisms of HIV disease. Annu Rev Pathol. 2011;6:223\u201348.","journal-title":"Annu Rev Pathol."},{"key":"1026_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/524143","volume":"197","author":"PW Hunt","year":"2008","unstructured":"Hunt PW, Brenchey J, Sinclair E, McCune JM, Roland M, Page-Shafer K, et al. Relationship between T cell activation and CD4 T cell count in VIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy. J Infect Dis. 2008;197:126\u201333.","journal-title":"J Infect Dis."},{"key":"1026_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/aid.2010.0107","volume":"27","author":"M L\u00f3pez","year":"2011","unstructured":"L\u00f3pez M, Soriano V, Peris-Pertusa A, Rall\u00f3n N, Benito JM. Elite controllers display higher activation on central memory CD8 T cells than HIV patients successfully on HAART. AIDS Res Hum Retrovir. 2011;27:157\u201365.","journal-title":"AIDS Res Hum Retrovir."},{"key":"1026_CR17","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1097\/QAD.0b013e3283519b22","volume":"26","author":"Y Yang","year":"2012","unstructured":"Yang Y, Al-Mozaini M, Buz\u00f3n MJ, Beamon J, Ferrando-Mart\u00ednez S, Ruiz-Mateos E, et al. CD4 T cell regeneration in HIV-1 elite controllers. AIDS. 2012;26:701\u20136.","journal-title":"AIDS."},{"key":"1026_CR18","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1097\/QAD.0b013e328357f5d1","volume":"26","author":"MM Sajadi","year":"2012","unstructured":"Sajadi MM, Pulijala R, Redfield RR, Talwani R. Chronic immune activation and decreased CD4 counts associated with hepatitis C infection in HIV-1 natural viral suppressors. AIDS. 2012;26:1879\u201384.","journal-title":"AIDS."},{"key":"1026_CR19","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1097\/QAD.0b013e328362dea4","volume":"27","author":"MM Sajadi","year":"2013","unstructured":"Sajadi MM, Redfield RR, Talwani R. Altered T-cell subsets in HIV-1 natural viral suppressors (elite controllers) with hepatitis C infection. AIDS. 2013;27:1989\u201395.","journal-title":"AIDS"},{"key":"1026_CR20","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1097\/QAD.0000000000001049","volume":"30","author":"CM Ramirez","year":"2016","unstructured":"Ramirez CM, Sinclair E, Epling L, Lee SA, Jain V, Hsue PY, et al. Immunologic profiles distinguish aviremic HIV-infected adults. AIDS. 2016;30:1553\u201362.","journal-title":"AIDS."},{"key":"1026_CR21","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.eimc.2011.06.002","volume":"29","author":"P Sobrino-Vegas","year":"2011","unstructured":"Sobrino-Vegas P, Guti\u00e9rrez F, Berenguer J, Labarga P, et al. [The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up.] In Spanish. Enferm Infecc Microbiol Clin. 2011;29:645\u201353.","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"1026_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-4690-6-27","volume":"6","author":"I Garc\u00eda-Merino","year":"2009","unstructured":"Garc\u00eda-Merino I, de Las CN, Jim\u00e9nez JL, Gallego J, G\u00f3mez C, Prieto C, et al. Spanish HIV BioBank. The Spanish HIV BioBank: a model of cooperative HIV research. Retrovirology. 2009;6:27.","journal-title":"Retrovirology"},{"key":"1026_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1093\/infdis\/jit581","volume":"209","author":"S Krishnan","year":"2014","unstructured":"Krishnan S, Wilson EM, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type-1 elite controllers. J Infect Dis. 2014;209:931\u20139.","journal-title":"J Infect Dis."},{"key":"1026_CR24","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1097\/QAD.0b013e32835a9950","volume":"26","author":"F Pereyra","year":"2012","unstructured":"Pereyra F, Lo J, Triant V, Wei A, Buzon M, Fitch K, et al. Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers. AIDS. 2012;26:2409\u201312.","journal-title":"AIDS."},{"key":"1026_CR25","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/QAD.0b013e32832b514b","volume":"23","author":"PY Hsue","year":"2009","unstructured":"Hsue PY, Hunt PW, Schnell A, Kalapus SC, Hoh R, Ganz P, et al. Role of viral replication, antiretroviral therapy and immunodeficiency in HIV-associated atherosclerosis. AIDS. 2009;23:1059\u201367.","journal-title":"AIDS."},{"key":"1026_CR26","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1093\/infdis\/jiu809","volume":"211","author":"TA Crowell","year":"2012","unstructured":"Crowell TA, Gebo KA, Blankson JN, Korthuis PT, Yehia BR, Rutsein RM, et al. Hospitalization rates and reasons among HIV elite controllers and persons with medically controlled HIV infection. J Infect Dis. 2012;211:1692\u2013702.","journal-title":"J Infect Dis."},{"key":"1026_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.2174\/157016210793499268","volume":"8","author":"E Ruiz-Mateos","year":"2010","unstructured":"Ruiz-Mateos E, Ferrando-Mart\u00ednez S, Machmach K, Viciana P, Pacheco YM, Nogales N, et al. High levels of CD57+CD28- T-cells, low T-cell proliferation and preferential expansion of terminally differentiated CD4+ T-cells in HIV-elite controllers. Curr HIV Res. 2010;8:471\u201381.","journal-title":"Curr HIV Res."},{"key":"1026_CR28","doi-asserted-by":"publisher","first-page":"e15924","DOI":"10.1371\/journal.pone.0015924","volume":"6","author":"PW Hunt","year":"2011","unstructured":"Hunt PW, Landay AL, Sinclair E, Martinson JA, Hatano H, Emu B, et al. A low regulatory cell response may contribute to both viral control and generalized immune activation in HIV controllers. PLoS One. 2011;6:e15924.","journal-title":"PLoS One."},{"key":"1026_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/nm.4241","volume":"23","author":"L Gattinoni","year":"2017","unstructured":"Gattinoni L, Speiser DE, Lichterfeld M, Bonini C. T memory cells in health and disease. Nat Med. 2017;23:18\u201327.","journal-title":"Nat Med."},{"key":"1026_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11904-014-0246-4","volume":"12","author":"A Chahroudi","year":"2015","unstructured":"Chahroudi A, Silvestri G, Lichterfeld M. T memory stem cells and HIV: a long term relationship. Curr HIV\/AIDS Rep. 2015;12:33\u201340.","journal-title":"Curr HIV\/AIDS Rep."},{"key":"1026_CR31","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","volume":"17","author":"L Gattinoni","year":"2011","unstructured":"Gattinoni L, Lugli E, Ji Y, Pos Z, Paulos CM, Quigkey MF, et al. A human memory T cell subset with stem cell-like properties. Nat Med. 2011;17:1290\u20137.","journal-title":"Nat Med."},{"key":"1026_CR32","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1093\/infdis\/jiu586","volume":"211","author":"JL Sanchez","year":"2015","unstructured":"Sanchez JL, Hunt PW, Reilly CS, Hatano H, Beilman GJ, Khoruts A, et al. Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions. J Infect Dis. 2015;211:1068\u201375.","journal-title":"J Infect Dis."},{"key":"1026_CR33","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cid\/ciw833","volume":"64","author":"B Dominguez-Molina","year":"2017","unstructured":"Dominguez-Molina B, Taranc\u00f3n-Diez L, Hua S, Abad-Molina C, Rodriguez-Gallego E, Machmach K, et al. HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers. Clin Infect Dis. 2017;64:321\u20138.","journal-title":"Clin Infect Dis."},{"key":"1026_CR34","doi-asserted-by":"publisher","first-page":"746","DOI":"10.3389\/fimmu.2017.00746","volume":"8","author":"SJ Westrop","year":"2017","unstructured":"Westrop SJ, Cocker ATH, Boasso A, Sullivan AK, Nelson MR, Imami N. Enrichment of HLA types and single-nucleotide polymorphism associated with non-progression in a strictly defined cohort of HIV-1 controllers. Front Immunol. 2017;8:746.","journal-title":"Front Immunol."},{"key":"1026_CR35","doi-asserted-by":"publisher","first-page":"ofu117","DOI":"10.1093\/ofid\/ofv117","volume":"2","author":"JZ Li","year":"2015","unstructured":"Li JZ, Arnold KB, Lo J, Dugast AS, Plants J, Ribaudo HJ, et al. Differential levels of soluble inflammatory markers by human immunodeficiency virus controller status and demographics. Open Forum Infect Dis. 2015;2:ofu117.","journal-title":"Open Forum Infect Dis"},{"key":"1026_CR36","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1097\/QAD.0000000000000860","volume":"29","author":"A Bansal","year":"2015","unstructured":"Bansal A, Sterret S, Erdman N, Westfall AO, Dionne-Odom J, Overton ET, et al. Normal T-cell activation in elite controllers with preserved CD4+ T-cell counts. AIDS. 2015;29:2245\u201354.","journal-title":"AIDS."},{"key":"1026_CR37","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1742-6405-8-20","volume":"8","author":"P Kamya","year":"2011","unstructured":"Kamya P, Tsoukas CM, Boulet S, Routy JP, Thomas R, C\u00f4te P, et al. T cell activation does not drive CD4 decline in longitudinally followed HIV-infected elite controllers. AIDS Res Ther. 2011;8:20\u20136.","journal-title":"AIDS Res Ther."},{"key":"1026_CR38","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1086\/605446","volume":"200","author":"F Pereyra","year":"2009","unstructured":"Pereyra F, Palmer S, Miura T, Block BL, Wiegand A, Rothchild AC, et al. Persistent low-level viremia in HIV-1 elite controllers and relationship to immunologic parameters. J Infect Dis. 2009;200:984\u201390.","journal-title":"J Infect Dis."},{"key":"1026_CR39","first-page":"382","volume":"2","author":"J Dock","year":"2011","unstructured":"Dock J, Effros RB. Role of CD8 T cell replicative senescence in human aging and in HIV-mediated immunosenescence. Aging Dis. 2011;2:382\u201397.","journal-title":"Aging Dis."},{"key":"1026_CR40","doi-asserted-by":"publisher","first-page":"3077","DOI":"10.1128\/JVI.77.5.3077-3083.2003","volume":"77","author":"M Dagarag","year":"2003","unstructured":"Dagarag M, Ng H, Lubong R, Effros RB, Yang OO. Differential impairment of lytic and cytokine functions in senescent human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J Virol. 2003;77:3077\u201383.","journal-title":"J Virol."},{"key":"1026_CR41","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.virol.2004.11.028","volume":"332","author":"OO Yang","year":"2005","unstructured":"Yang OO, Lin H, Dagarag M, Ng HL, Effros RB, Uittenbogaart CH. Decreased perforin and granzyme B expression in senescent HIV-1-specific cytotoxic T lymphocytes. Virology. 2005;332:16\u20139.","journal-title":"Virology."},{"key":"1026_CR42","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/QAI.0b013e3181fbab9f","volume":"56","author":"K Grabmeier-Pfistershammer","year":"2011","unstructured":"Grabmeier-Pfistershammer K, Steinberger P, Rieger A, Leitner J, Kohrgruber N. Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment. J Acquir Immune Defic Syndr. 2011;56:118\u201324.","journal-title":"J Acquir Immune Defic Syndr."},{"key":"1026_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2334-11-43","volume":"11","author":"D Nakanjako","year":"2011","unstructured":"Nakanjako D, Ssewanyana I, Mayanja-Kizza H, Kiragga A, Colebunders R, Manabe YC, et al. High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort. BMC Infect Dis. 2011;11:43.","journal-title":"BMC Infect Dis."}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-018-1026-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T23:38:05Z","timestamp":1751413085000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-018-1026-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,28]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1026"],"URL":"https:\/\/doi.org\/10.1186\/s12916-018-1026-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732784114.793547585","asserted-by":"object"}]},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,28]]},"assertion":[{"value":"20 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"To participate in the study, written informed consent was obtained from all individuals. The study protocol was evaluated and approved by the institutional ethical committee of Carlos III Hospital with reference number HCIII-P3\/14.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"30"}}